Cefdinir
Cefdinir is a cephalosporin antibiotic used to treat mild to moderate bacterial infections of the lungs, sinuses, throat, ears (in children) and skin.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 81 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Cefdinir (Omnicef) is a cephalosporin antibiotic that attacks bacterial cell walls. It is used for mild to moderate pneumonia, sinus infections, strep throat, skin infections and children's ear infections, and it is a common pick when amoxicillin is not a good fit, around since the late 1990s and available as a generic. Most people handle it well. Loose stools and nausea are the usual complaints, and young children often get diaper rash. Mention any penicillin or cephalosporin allergy before starting, and get emergency help for trouble breathing or facial swelling. Call your doctor about severe or bloody diarrhea, even weeks later, since it can signal C. difficile, a serious colon infection.
Clinical pearls
- Take cefdinir at least 2 hours before or after aluminum or magnesium antacids and iron supplements, since they block absorption.
- Reddish stools are harmless, caused by cefdinir binding iron in the gut, and iron-fortified infant formula is fine to keep using.
- A penicillin allergy does not rule cefdinir out, but a past cephalosporin allergy does, so describe exactly what reaction you had.
- With kidney disease or dialysis the dose may need lowering, since full cephalosporin doses have been linked to seizures.
Patient information guide A plain-language walkthrough of Cefdinir, written from its FDA label.
What Cefdinir is used for
▾
Cefdinir treats mild to moderate bacterial infections in these areas:
- Community-acquired pneumonia (adults and adolescents)
- Acute flare-ups of chronic bronchitis (adults and adolescents)
- Acute maxillary sinusitis, a sinus infection (adults and adolescents)
- Pharyngitis/tonsillitis caused by Streptococcus pyogenes, meaning strep throat and tonsil infection (adults, adolescents and children)
- Uncomplicated skin and skin structure infections (adults, adolescents and children)
- Acute bacterial otitis media, a middle ear infection (children)
Cefdinir has not been studied for preventing rheumatic fever after strep throat. Only intramuscular penicillin has been shown to do that.
Cefdinir dosage
▾
Cefdinir is taken by mouth, once or twice daily, usually for 5 to 10 days depending on the infection. Food does not matter.
- Cefdinir capsules are for adults and adolescents 13 and older. Pneumonia and skin infections need twice-daily dosing.
- Cefdinir for oral suspension is for children 6 months through 12 years. Dosing is by body weight, and skin infections need twice-daily dosing.
- People with severe kidney disease or on hemodialysis get adjusted schedules.
Follow your prescriber and the label, and finish the full course.
Dosing details from the FDA-approved label
From the Cefdinir prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Community-Acquired Pneumonia (adults and adolescents age 13 years and older, capsules)
- 300 mg q12h for 10 days
- Maximum: Total daily dose for all infections is 600 mg
- Once-daily dosing has not been studied in pneumonia; give twice daily
- Acute Exacerbations of Chronic Bronchitis (adults and adolescents age 13 years and older, capsules)
- 300 mg q12h for 5 to 10 days or 600 mg q24h for 10 days
- Maximum: Total daily dose for all infections is 600 mg
- May be taken without regard to meals
- Acute Maxillary Sinusitis (adults and adolescents age 13 years and older, capsules)
- 300 mg q12h for 10 days or 600 mg q24h for 10 days
- Maximum: Total daily dose for all infections is 600 mg
- May be taken without regard to meals
- Pharyngitis/Tonsillitis (adults and adolescents age 13 years and older, capsules)
- 300 mg q12h for 5 to 10 days or 600 mg q24h for 10 days
- Maximum: Total daily dose for all infections is 600 mg
- May be taken without regard to meals
- Uncomplicated Skin and Skin Structure Infections (adults and adolescents age 13 years and older, capsules)
- 300 mg q12h for 10 days
- Maximum: Total daily dose for all infections is 600 mg
- Once-daily dosing has not been studied in skin infections; give twice daily
- Acute Bacterial Otitis Media (pediatric patients age 6 months through 12 years)
- 7 mg/kg q12h for 5 to 10 days or 14 mg/kg q24h for 10 days
- Maximum: 14 mg/kg total daily dose, up to a maximum of 600 mg per day
- Patients weighing ≥ 43 kg should receive the maximum daily dose of 600 mg
- Acute Maxillary Sinusitis (pediatric patients age 6 months through 12 years)
- 7 mg/kg q12h for 10 days or 14 mg/kg q24h for 10 days
- Maximum: 14 mg/kg total daily dose, up to a maximum of 600 mg per day
- Patients weighing ≥ 43 kg should receive the maximum daily dose of 600 mg
- Pharyngitis/Tonsillitis (pediatric patients age 6 months through 12 years)
- 7 mg/kg q12h for 5 to 10 days or 14 mg/kg q24h for 10 days
- Maximum: 14 mg/kg total daily dose, up to a maximum of 600 mg per day
- Patients weighing ≥ 43 kg should receive the maximum daily dose of 600 mg
- Uncomplicated Skin and Skin Structure Infections (pediatric patients age 6 months through 12 years)
- 7 mg/kg q12h for 10 days
- Maximum: 14 mg/kg total daily dose, up to a maximum of 600 mg per day
- Once-daily dosing has not been studied in skin infections; give twice daily
- Renal insufficiency (creatinine clearance < 30 mL/min)
- Adults: 300 mg given once daily
- Pediatric patients (CLcr < 30 mL/min/1.73 m2): 7 mg/kg (up to 300 mg) given once daily
- Maximum: 300 mg
- Hemodialysis: 300 mg or 7 mg/kg every other day, with 300 mg (or 7 mg/kg) given at the end of each session
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION (See INDICATIONS AND USAGE for Indicated Pathogens.) Powder for Oral Suspension The recommended dosage and duration of treatment for infections in pediatric patients are described in the following chart; the total daily dose for all infections is 14 mg/kg, up to a maximum dose of 600 mg per day. Once-daily dosing for 10 days is as effective as BID dosing. Once-daily dosing has not been studied in skin infections; therefore, cefdinir for oral suspension USP should be administered twice daily in this infection. Cefdinir for oral suspension USP may be administered without regard to meals. Pediatric Patients (Age 6 Months Through 12 Years) Type of Infection Dosage Duration Acute Bacterial Otitis Media 7 mg/kg q12h 5 to 10 days or 14 mg/kg q24h 10 days Acute Maxillary Sinusitis 7 mg/kg q12h 10 days or 14 mg/kg q24h 10 days Pharyngitis/Tonsillitis 7 mg/kg q12h 5 to 10 days or 14 mg/kg q24h 10 days Uncomplicated Skin and Skin Structure Infections 7 mg/kg q12h 10 days CEFDINIR FOR ORAL SUSPENSION PEDIATRIC DOSAGE CHART Weight 125 mg/5 mL 250 mg/5 mL 9 kg/20 lbs 2.5 mL q12h or 5 mL q24h Use 125 mg/5 mL product 18 kg/40 lbs 5 mL q12h or 10 mL q24h 2.5 mL q12h or 5 mL q24h 27 kg/60 lbs 7.5 mL q12h or 15 mL q24h 3.75 mL q12h or 7.5mL q24h 36 kg/80 lbs 10 mL q12h or 20 mL q24h 5 mL q12h or 10 mL q24h ≥ 43 kg 1 /95 lbs 12 mL q12h or 24 mL q24h 6 mL q12h or 12 mL q24h 1. Pediatric patients who weigh ≥ 43 kg should receive the maximum daily dose of 600 mg. Patients With Renal Insufficiency For adult patients with creatinine clearance < 30 mL/min, the dose of cefdinir should be 300 mg given once daily. Creatinine clearance is difficult to measure in outpatients. However, the following formula may be used to estimate creatinine clearance (CL cr ) in adult patients. For estimates to be valid, serum creatinine levels should reflect steady-state levels of renal function. Males: CL cr = (weight) (140 − age) (72) (serum creatinine) Females: CL cr = 0.85 × above value where creatinine clearance is in mL/min, age is in years, weight is in kilograms, and serum creatinine is in mg/dL. 1 The following formula may be used to estimate creatinine clearance in pediatric patients: CL cr = K × body length or height serum creatinine where K = 0.55 for pediatric patients older than 1 year 2 and 0.45 for infants (up to 1 year) 3 .
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Cefdinir side effects
▾
Most side effects are mild and go away on their own. The most common are:
Common side effects
- Diarrhea
- Nausea
- Headache
- Abdominal pain
- Vaginal yeast infection or vaginitis in women
- Rash (diaper rash is common in young children)
- Indigestion, gas or vomiting
- Rash, especially diaper rash in children 2 and younger
When to get medical help
- Signs of a serious allergic reaction, such as trouble breathing, swelling of the face or throat, or a severe rash. Get emergency help.
- Severe or bloody diarrhea, even weeks or months after finishing the antibiotic. Call your doctor.
- Blistering or peeling skin, or sores in the mouth. Call your doctor right away.
- Yellowing of the skin or eyes, or signs of liver problems. Call your doctor.
- A seizure. Cephalosporins have been linked to seizures, especially in people with kidney problems when the dose was not lowered.
Cefdinir warnings and precautions
▾
- Serious allergic reactions can happen. Cross-reactions with penicillin allergy can occur in up to 10% of those with that history.
- C. difficile diarrhea can range from mild to fatal colitis and may appear over two months after treatment.
- Antibiotics should only be used for infections that are proven or strongly suspected to be bacterial, which helps prevent drug-resistant bacteria.
- Seizures have been reported with cephalosporins, especially in people with kidney problems whose dose was not lowered.
Cefdinir interactions
▾
A few products change how well cefdinir works or how long it stays in the body:
- Aluminum- or magnesium-containing antacids: lower absorption by about 40%. Separate by at least 2 hours.
- Iron supplements: can lower absorption by up to 80%. Separate by at least 2 hours.
- Probenecid: slows kidney clearance and roughly doubles drug exposure.
- Iron-containing products: may cause harmless reddish stools.
Interactions listed in the FDA-approved label
From the Cefdinir prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Antacids (Aluminum- or Magnesium-Containing): Taking 300 mg cefdinir capsules with 30 mL Maalox TC suspension reduces the rate (Cmax) and extent (AUC) of absorption by approximately 40% and prolongs time to Cmax by 1 hour. Take cefdinir at least 2 hours before or after the antacid; no significant effect if the antacid is given 2 hours before or after cefdinir.
- Probenecid: Probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in AUC, a 54% increase in peak plasma levels, and a 50% prolongation in apparent elimination t½.
- Iron supplements: A therapeutic iron supplement with 60 mg elemental iron (as FeSO4) reduced extent of absorption by 80%, and vitamins with 10 mg elemental iron reduced it by 31%. Take cefdinir for oral suspension at least 2 hours before or after the supplement.
- Foods highly fortified with iron (e.g., iron-fortified breakfast cereals): The effect on cefdinir absorption has not been studied.
- Iron-fortified infant formula: Iron-fortified infant formula (2.2 mg elemental iron/6 oz) has no significant effect on cefdinir pharmacokinetics. Cefdinir for oral suspension can be administered with iron-fortified infant formula.
Read the label’s full interactions text
Drug Interactions Antacids (Aluminum- or Magnesium-Containing) Concomitant administration of 300 mg cefdinir capsules with 30 mL Maalox ® TC suspension reduces the rate (C max ) and extent (AUC) of absorption by approximately 40%. Time to reach C max is also prolonged by 1 hour. There are no significant effects on cefdinir pharmacokinetics if the antacid is administered 2 hours before or 2 hours after cefdinir. If antacids are required during cefdinir for oral suspension therapy, cefdinir for oral suspension should be taken at least 2 hours before or after the antacid. Probenecid As with other β-lactam antibiotics, probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in AUC, a 54% increase in peak cefdinir plasma levels, and a 50% prolongation in the apparent elimination t ½ . Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO 4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively. If iron supplements are required during cefdinir for oral suspension therapy, cefdinir for oral suspension should be taken at least 2 hours before or after the supplement. The effect of foods highly fortified with elemental iron (primarily iron-fortified breakfast cereals) on cefdinir absorption has not been studied. Concomitantly administered iron-fortified infant formula (2.2 mg elemental iron/6 oz) has no significant effect on cefdinir pharmacokinetics. Therefore, cefdinir for oral suspension can be administered with iron-fortified infant formula. There have been reports of reddish stools in patients receiving cefdinir. In many cases, patients were also receiving iron-containing products. The reddish color is due to the formation of a nonabsorbable complex between cefdinir or its breakdown products and iron in the gastrointestinal tract.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Cefdinir
▾
- Do not take cefdinir if you are allergic to cephalosporin antibiotics.
- Tell your prescriber about any past reaction to penicillins or other drugs.
- Tell your prescriber if you have kidney disease or are on dialysis.
- Children’s doses depend on weight.
Cefdinir overdose
▾
Information on overdose in humans is not available. Overdose with similar antibiotics has caused nausea, vomiting, stomach discomfort, diarrhea and convulsions. Hemodialysis removes cefdinir from the body, which may help in a serious reaction, especially with poor kidney function.
How your body processes Cefdinir
▾
Cefdinir reaches its highest blood level about 2 to 4 hours after a dose. Only a portion is absorbed, and food has little clinically important effect. It does not build up in the body with once- or twice-daily dosing when kidneys work normally. Hemodialysis removes it, and probenecid slows its removal. It reaches skin, tonsil and sinus tissue.
How to store Cefdinir
▾
Store the unsuspended powder at 20° to 25°C (68° to 77°F) . stored at controlled room temperature for 10 days.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Cefdinir
60 supplements and herbal products have documented interactions with Cefdinir in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 3
- Moderate · 46
- Minor · 11
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Cefdinir has been associated with lower levels of 7 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
- Higher significance · 6
- Moderate · 1
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Cefdinir: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Cefdinir — the kind of thing our pharmacy team would talk through with you at the counter.
What is cefdinir used for?
▾
Do I need to take it with food?
▾
I take an antacid or iron. Is that a problem?
▾
Why are my stools red?
▾
What side effects should I expect?
▾
I’m allergic to penicillin. Can I still take it?
▾
Is Cefdinir available over the counter?
▾
When was Cefdinir first available?
▾
Who makes Cefdinir?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Cefdinir on HelloPharmacist
Cefdinir forms and strengths (how it comes)
Cefdinir is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Capsule
How this form is used
- Cefdinir capsules are used in adults and adolescents for community-acquired pneumonia, chronic bronchitis flare-ups, sinus infections, throat and tonsil infections, and uncomplicated skin infections.
- Cefdinir capsules may be taken with or without food.
- Cefdinir capsules are given twice daily for pneumonia and skin infections; other infections may allow once- or twice-daily dosing.
- Cefdinir capsules should be taken at least 2 hours before or after antacids and iron supplements.
- The label notes that the oral suspension may be better suited for children.
Oral suspension
How this form is used
- Cefdinir for oral suspension is used in children for middle ear infections, throat and tonsil infections, and uncomplicated skin infections.
- Cefdinir for oral suspension is also labeled for use in adults and adolescents for pneumonia, chronic bronchitis flare-ups and sinus infections.
- Cefdinir for oral suspension is mixed with water as directed, and the bottle should be shaken well before each dose.
- Cefdinir for oral suspension may be used for 10 days after mixing, then any leftover must be thrown away.
- Cefdinir for oral suspension can be given with or without food and with iron-fortified infant formula.
- Cefdinir for oral suspension should be taken at least 2 hours before or after antacids and iron supplements.
Cefdinir on the U.S. market: products, makers and brands
How Cefdinir appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
21 companies list 78 Cefdinir product records with the FDA, mostly as capsule, oral suspension; the earliest marketing or approval year on record is 1997. Brand names on the directory include Omnicef; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (6) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Cefdinir is used (Medicaid data)
A general measure of how commonly Cefdinir is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Cefdinir is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Cefdinir prescribed? Of the 1,601 medications we measure, Cefdinir ranks #99 by Medicaid prescriptions — more than 94% of them.
Utilization by Cefdinir product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
cefdinir 50 MG/ML Oral Suspension Most dispensed
Summed across the 8 of 39 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 476576
cefdinir 300 MG Oral Capsule
Summed across the 8 of 123 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 200346
cefdinir 25 MG/ML Oral Suspension
Summed across the 8 of 32 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309054
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Cefdinir, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 24 of 194 listed Cefdinir NDCs with Medicaid activity.
Compare Cefdinir products
A representative set of FDA-listed product records for Cefdinir — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 300 mg | Oral | A-S Medication Solutions × 4 listings | ANDA | View NDC → |
| 300 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 300 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 300 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 300 mg | Oral | AvKARE | ANDA | View NDC → |
| 300 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 300 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | DirectRx | ANDA | View NDC → |
| 300 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 300 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 300 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 300 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 300 mg | Oral | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 300 mg | Oral | NuCare Pharmaceuticals,Inc. × 6 listings | ANDA | View NDC → |
| 300 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 5 listings | ANDA | View NDC → |
| 300 mg | Oral | Preferred Pharmaceuticals, Inc. | ANDA | View NDC → |
| 300 mg | Oral | Preferred Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Proficient Rx LP × 3 listings | ANDA | View NDC → |
| 300 mg | Oral | Redpharm Drug, Inc. | ANDA | View NDC → |
| 300 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 300 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 300 mg | Oral | Sandoz Inc | ANDA | View NDC → |
| 300 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 💊Oral suspension | ||||
| 125 mg/5 mL | Oral | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 250 mg/5 mL | Oral | A-S Medication Solutions × 5 listings | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Asclemed USA, Inc. | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Asclemed USA, Inc. | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Direct Rx | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Direct Rx × 3 listings | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 125 mg/5 mL | Oral | NuCare Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 125 mg/5 mL | Oral | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 250 mg/5 mL | Oral | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Preferred Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Proficient Rx LP | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Proficient Rx LP × 3 listings | ANDA | View NDC → |
| 125 mg/5 mL | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
Showing 78 of 78 products — FDA National Drug Code Directory. See every product, package size and price: browse all 78 Cefdinir NDCs →
Cefdinir side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Cefdinir — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Cefdinir are diarrhoea, chronic kidney disease, pneumonia; about 63% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Cefdinir in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Cefdinir FDA approval history
How Cefdinir went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Cefdinir was first approved by the FDA in 1997 (Brand: OMNICEF · Abbvie); the first generic version was approved in 2006. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Cefdinir recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 2 Cefdinir recalls since July 2021, covering 3 product listings. None of them is still listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462… Lots: Lot #F305184, F305185, F305186, Exp 7/31/ 2025 FDA record D-0518-2024 →
- Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured b… Lots: Lot # F305292, Exp 8/30/2025 FDA record D-0497-2024 →
- Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured b… Lots: Lot # F305442, Exp 8/30/2025 FDA record D-0496-2024 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 25037 2 dose forms · 3 strengths
-
Dose form (SCDF) Oral Capsule RxCUI 371325In current FDA listingsClinical drug / strength (SCD) 300 MGRxCUI 200346 -
Dose form (SCDF) Oral Suspension RxCUI 371326In current FDA listings
Look up RxCUI 25037 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Cefdinir supply and shortage status
Whether Cefdinir is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Cefdinir costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Capsule · Oral | 300 mg | $0.458 per capsule | NDC details & price history |
| Capsule | 300 mg | $0.458 per capsule | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Cefdinir brand names
Cefdinir is sold under one brand name in the FDA directory — Omnicef. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Cefdinir: manufacturers and labelers
21 companies list Cefdinir products with the FDA. By number of product records, the largest are NuCare Pharmaceuticals,Inc., A-S Medication Solutions, Preferred Pharmaceuticals Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Cefdinir drug class (RxNorm)
Cefdinir belongs to the Cephalosporin Antibacterial class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Cefdinir page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Proficient Rx LP is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →